Search Results for "Bioserve Pharma Product Fly On"
Original Source: BIOSERV Analytik und Medizinprodukte GmbH
BIOSERV Analytics is a business segment of BIOSERV Analytics and Medical Devices (BIOSERV Analytik und Medizinprodukte GmbH).The Headquarter of BIOSERV is located in Rostock, a lovely port at the Baltic Sea, about 2 hours by car or train from Hamburg in the west and Berlin in the South.The Business segments of BIOSERV Analytics and Medical Devices areAnalytics: chemical, physical, physicochemical, sensoric etc. testing of food products, pharmaceutical products and others
Matching Channels
The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...
Devices - medical, biotech, pharma
A medical device is a product which is used for medical purposes in patients, in diagnosis, therapy or surgery. Medical devices act by physical, mechanical, thermal, physico-chemical or chemic...
Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...
OxyContin, an narcotic analgesic produced by Purdue Pharma LP, nets $3m in sales annually, placing it 8th in the world for annual sales. OxyContin in the brand name for oxycodone, and is similar t...
Lyxumia® is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) for the treatment of patients with type 2 diabetes mellitus. GLP-1 is a naturally-occurring peptide hormone that is re...
Matching News
BioServe: One of the Largest Commercial Biobanks in the World
In this episode of PharmaTelevision News Review, Fintan Walton talks to Rob Fannon, Clinical Operations Manager at BioServe. They discuss: • BioServe 's Origins and focus • Biobanks,sample tissue...
DNA Genotek and BioServe BioTechnologies are providing support for a new genomic study into craniofacial anomalies (cleft lip and palate) in Ethiopia. Ottawa, ON (PRWEB) August 02, 2012 DNA Genotek,...
BioAlliance Pharma licenses oncology product to Vestiq Pharmaceuticals
BioAlliance Pharma SA has completed a licensing agreement with Vestiq Pharmaceuticals for Vestiq to commercialise its product Oravig in the USA for the treatment of oropharyngeal candidiasis in adults...
A.P. Pharma raising $53.6 million
A.P. Pharma Inc. (OTCBB:APPA) said it plans to raise $53.6 million through the sale of 102 million shares at $0.53 to institutional investors. The price is a 20% discount to A.P. Pharma's Tuesday clos...
Valeant and Actavis signs pharma deals for Herpes simplex treatment
Actavis and Valeant , two big pharma companies,sign pharma deals, effective immediately, for Actavis to be the exclusive marketer and distributor of an authorized generic of Valeant’s Zovirax oi...
GlaxoSmithKline big pharma deals with DKSH for antibiotics
Big pharma company, GlaxoSmithKline, has signed a pharma deals agreement with DKSH for them to provide contract sales services in both private clinics and trade channel for the big pharma company̵...
Recipharm and Astimex Pharma in development and manufacturing collaboration
Recipharm AB and Astimex Pharma AB have established a collaboration agreement for the development and manufacture of a pharmaceutical product. Formulation development work will take place at the Recip...
ZS Pharma raises $46M in C round
ZS Pharma Inc. (Fort Worth, Texas) raised $46 million in a series C round led by Alta Partners. Existing investor Devon Park Bioventures joined new investors RiverVest Venture Partners; 3x5 Special Op...
Matching PubMed Articles
Natural products and Pharma 2011: Strategic changes spur new opportunities.
Although natural products have been marginalized by major pharmaceutical companies over the last 20-30 years, the changing landscape of drug discovery now favors a greatly enhanced role for Nature's p...
PURPOSE: The objective of the study was to investigate the relative bioavailability between the generic tacrolimus products that are presently authorized in Spain by adjusted indirect comparison. This...
Structures containing the (R)-3-amino-3-methyl piperidine unit as a new pharmacophore moiety have been shown to possess moderate inhibitory activity for DPP-4 with good pharmacokinetics profile. One o...
Impurities found in stressed and stability studies of Olanzapine (polymorphic form-I) [1-7] in both drug substance and drug product are described. These impurities are identified as 4-(4-methyl-1-pipe...
